文献速递妇科

使用被动自采集月经血筛查高危人乳头瘤病毒

Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood.
PubMed 文献 · Obstet Gynecol · 2022-08-03

本前瞻性观察研究纳入153名女性,评估改良月经垫与医生采集样本的高危HPV检测一致性及可接受性,106人提供月经垫样本和医生采集宫颈标本。间隔小于2个月时一致性为94%(95%CI 83-98),月经垫采样总体受94.0%参与者偏好。

要点

  • 月经垫与医生采集标本的高危HPV检测一致性达94%(95%CI 83-98,间隔<2个月)。
  • 在HPV阳性或CIN2以上女性中,月经垫与医生采集标本一致率为100%(95%CI 32.5-100)。
  • 94.0%参与者偏好月经垫采样,22.9%对自采阴道拭子表示不适并选择不采集。

核心结论

  • 在HPV检测阳性的女性中,月经垫与医生采集样本结果高度一致;该采集方式有望整合进宫颈癌预防项目。

研究设计与样本

  • 前瞻性观察研究,纳入因宫颈癌筛查或高危HPV阳性史就诊的女性,要求提供医生采集宫颈标本、自采阴道拭子和改良月经垫三种样本,均用Cobas HPV检测处理。
  • 153名女性入组,其中106人提供了月经垫样本和医生采集宫颈标本用于高危HPV分析。

主要发现

  • 医生采集标本与月经垫样本间隔小于2个月时,一致性为94%(95%CI 83-98)。
  • 在因常规筛查就诊的高危HPV阳性女性及超过宫颈上皮内瘤变2级的女性中,月经垫与医生采集标本一致率为100%(95%CI 32.5-100)。
  • 22.9%参与者对自采阴道拭子表示不适并选择不采集。
  • 94.0%参与者偏好月经垫而非医生采集采样。
  • 12名患者月经垫样本HPV阳性而医生采集标本阴性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess concordance and acceptability of a modified menstrual pad compared with a clinician-collected high-risk human papillomavirus (HPV) sample. METHODS: This was a prospective observational study. Women presenting for either cervical cancer screening or with a history of high-risk HPV positivity were eligible. Three samples were requested from participants: 1) clinician-collected cervical specimens; 2) self-collected vaginal swabs; and 3) a modified menstrual pad, which was taken home for use during the next menstruation. All samples were processed using the Cobas HPV test. Menstrual pad dried blood spots were eluted, then similarly processed. RESULTS: Of 153 women enrolled in the study, 106 provided menstrual pad samples and clinician-collected cervical specimens for high-risk HPV analysis. For samples in which the interval between the clinician-collected specimen and the menstrual pad sample was less than 2 months, the concordance was 94% (95% CI 83-98). For women who tested positive for high-risk HPV who presented for general screening and those with more than cervical intraepithelial neoplasia 2, menstrual pad and clinician-collected specimen agreement was 100% (95% CI 32.5-100). Among participants, 22.9% expressed discomfort with the self-collected vaginal swabs and opted out of collection. Overall, 94.0% of participants preferred the menstrual pad over clinician-collected sampling. Twelve patients were found to be positive for HPV on the menstrual pad sample but negative on the clinician-collected specimen. CONCLUSION: Among women who tested positive for HPV, the menstrual pad showed highly concordant results compared with clinician-collected sampling. This collection approach shows promise for integration into cervical cancer prevention programs.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Naseri S, Young S, Cruz G, et al. Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood. Obstet Gynecol. 2022. PMID: 35926207. doi:10.1097/AOG.0000000000004904

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。